Atlas Trials

Evaluation of cfDNA as a Marker of Response in Rectal Cancer

Clinical trial NCT04319354 · COMPLETED

Trial details

NCT number
NCT04319354
Sponsor
Hospital Pedro Hispano
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cancer of Rectum
Start date
2019-11-18
Primary completion
2021-04-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.